Testing effectiveness (Phase 2)Study completedNCT00881946What this trial is testingRepeat Dose Safety Study for Compound to Treat Hematologic CancerWho this might be right forHematologic Malignancies Accenture 73
Early research (Phase 1)Ended earlyNCT04887259What this trial is testingTrial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AMLWho this might be right forChronic Lymphocytic LeukemiaMultiple MyelomaAcute Myeloid Leukemia Lava Therapeutics 16
Testing effectiveness (Phase 2)Ended earlyNCT00281879What this trial is testingDonor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 200
Testing effectiveness (Phase 2)Study completedNCT01030718What this trial is testingRollover Study of BMS-354825 in Patients With CML and Ph+ALLWho this might be right forChronic Myelogenous LeukemiaPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia Bristol-Myers Squibb 54
Testing effectiveness (Phase 2)Ended earlyNCT02795520What this trial is testingPharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous LeukemiaWho this might be right forAMLAdvanced MDSALL+2 more OncoTherapy Science, Inc. 32
Testing effectiveness (Phase 2)Study completedNCT01254890What this trial is testingSorafenib and 5-Azacitidine in Acute Leukemia + Myelodysplastic SyndromeWho this might be right forLeukemia M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00004918What this trial is testingVaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic SyndromeWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionChronic Phase Chronic Myelogenous Leukemia+4 more National Cancer Institute (NCI) 69
Testing effectiveness (Phase 2)Study completedNCT00064376What this trial is testingParicalcitol in Treating Patients With Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes Cedars-Sinai Medical Center
Large-scale testing (Phase 3)Study completedNCT00678275What this trial is testingChronic Graft-versus-host Disease (cGvHD) Prophylaxis With or Without ATG Prior to Stem Cell Transplantation (SCT) From HLA-identical Siblings in Patients With Acute LeukemiaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia Universitätsklinikum Hamburg-Eppendorf 161
Testing effectiveness (Phase 2)Study completedNCT00955916What this trial is testingCLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML)Who this might be right forLeukemia H. Lee Moffitt Cancer Center and Research Institute 38
Testing effectiveness (Phase 2)Study completedNCT00719836What this trial is testingSB1518 for the Treatment of Advanced Myeloid MalignanciesWho this might be right forAcute Myelogenous LeukemiaChronic Myelogenous LeukemiaChronic Myelomonocytic Leukemia+2 more S*BIO 76
Not applicableStudy completedNCT01395628What this trial is testingCell Samples From Patients With LeukemiaWho this might be right forLeukemia Children's Oncology Group 10
Not applicableStudy completedNCT00521430What this trial is testingDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Asan Medical Center 30
Early research (Phase 1)Study completedNCT00005593What this trial is testingFludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic SyndromeWho this might be right forLeukemiaMyelodysplastic Syndromes Case Comprehensive Cancer Center 31
Not applicableLooking for participantsNCT07549516What this trial is testingA Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in GermanyWho this might be right forLeukemia, Chronic Myeloid Novartis Pharmaceuticals 380
Early research (Phase 1)Study completedNCT00438178What this trial is testingSafety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological MalignanciesWho this might be right forHematological Malignancies Gemin X 44
Testing effectiveness (Phase 2)Study completedNCT00005797What this trial is testingBone Marrow Transplant in Treating Patients With Hematologic CancersWho this might be right forChronic Myeloproliferative DisordersLeukemiaMultiple Myeloma and Malignant Plasma Cell Neoplasms+2 more H. Lee Moffitt Cancer Center and Research Institute 125
Early research (Phase 1)Looking for participantsNCT07651878What this trial is testingPhase I Trial of Vididencel in CML-CP Patients With MRD Under TKI TreatmentWho this might be right forCML (Chronic Myelogenous Leukemia) Mendus 24
Not applicableStudy completedNCT02842333What this trial is testingStudy of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase InhibitorWho this might be right forChronic Leukemia Centre Hospitalier Universitaire de Besancon 57
Early research (Phase 1)Ended earlyNCT05787496What this trial is testingA Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid NeoplasmsWho this might be right forRelapsed or Refractory Acute Myeloid LeukemiaRelapsed or Refractory Chronic Myelomonocytic LeukemiaRelapsed or Refractory Myelodysplastic Syndrome NextCure, Inc. 28